{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:48:33Z","timestamp":1770418113300,"version":"3.49.0"},"reference-count":7,"publisher":"Japanese Pharmacological Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Folia Pharmacologica Japonica","Folia Pharmacol. Jpn."],"published-print":{"date-parts":[[2019]]},"DOI":"10.1254\/fpj.153.79","type":"journal-article","created":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T22:44:47Z","timestamp":1549665887000},"page":"79-87","source":"Crossref","is-referenced-by-count":7,"title":["Drug properties of fosravuconazole L-lysine ethanolate (NAILIN<sup>\u00ae<\/sup> Capsules 100\u2005mg), a new oral azole therapeutic for onychomycosis: an analysis based on non-clinical and clinical trial data","\u65b0\u898f\u30a2\u30be\u30fc\u30eb\u7cfb\u7d4c\u53e3\u722a\u767d\u766c\u6cbb\u7642\u85ac\u30db\u30b9\u30e9\u30d6\u30b3\u30ca\u30be\u30fc\u30ebL-\u30ea\u30b7\u30f3\u30a8\u30bf\u30ce\u30fc\u30eb\u4ed8\u52a0\u7269\uff08\u30cd\u30a4\u30ea\u30f3<sup>\u00ae<\/sup>\u30ab\u30d7\u30bb\u30eb100\u2005mg\uff09\u306e\u975e\u81e8\u5e8a\u8a66\u9a13\u304a\u3088\u3073\u81e8\u5e8a\u8a66\u9a13\u304b\u3089\u307f\u305f\u85ac\u7269\u7279\u6027"],"prefix":"10.1254","volume":"153","author":[{"given":"Makoto","family":"Nakano","sequence":"first","affiliation":[{"name":"Sato Pharmaceutical Co Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Aoki","sequence":"additional","affiliation":[{"name":"Sato Pharmaceutical Co Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyo","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Teikyo University Institute of Medical Mycology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2) Watanabe S, et al. J Dermatol. 2010;37:397-406.","DOI":"10.1111\/j.1346-8138.2009.00741.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"6) Yamaguchi H. Med Mycol J. 2016;57E:E93-E110.","DOI":"10.3314\/mmj.16-00006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"7) Ueda Y, et al. Bioorg Med Chem Lett. 2003;13:3669-3672.","DOI":"10.1016\/j.bmcl.2003.08.029"},{"key":"4","doi-asserted-by":"crossref","unstructured":"9) Gupta A, et al. J Eur Acad Dermatol Venereol. 2005;19:437-443.","DOI":"10.1111\/j.1468-3083.2005.01212.x"},{"key":"5","unstructured":"12) Lepak AJ, et al. Cold Spring Harb Perspect Med. 2014;5:1-23."},{"key":"6","doi-asserted-by":"crossref","unstructured":"13) Andes D, et al. Antimicrob Agents Chemother. 2003;47:1193-1199.","DOI":"10.1128\/AAC.47.4.1193-1199.2003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"14) Watanabe S, et al. J Dermatol. 2018;45:1151-1159.","DOI":"10.1111\/1346-8138.14607"}],"container-title":["Folia Pharmacologica Japonica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/153\/2\/153_79\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T04:29:41Z","timestamp":1549686581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/153\/2\/153_79\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1254\/fpj.153.79","relation":{},"ISSN":["0015-5691","1347-8397"],"issn-type":[{"value":"0015-5691","type":"print"},{"value":"1347-8397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}